Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
UBS Group
UBS
$173B
| $80.1M | 0.09% |
4,449,243
+4,245,517
| +2,084% | +$73.9M |
|
202
CALL
Netflix
NFLX
$299B
| $79.3M | 0.09% |
13,349,000
-15,820,000
| -54% | -$96M |
|
203
Cigna
CI
$73.7B
| $79M | 0.09% |
612,548
+252,226
| +70% | +$29.3M |
|
204
PUT
WisdomTree Japan Hedged Equity Fund
DXJ
$7.18B
| $79M | 0.09% |
1,436,400
+985,500
| +219% | +$51.3M |
|
205
Halliburton
HAL
$26.9B
| $78M | 0.09% |
1,814,625
-374,798
| -17% | -$15.6M |
|
|
206
CALL
Verizon
VZ
$195B
| $77.6M | 0.09% |
1,616,078
+611,780
| +61% | +$29.5M |
|
207
Danaher
DHR
$137B
| $77.1M | 0.09% |
1,365,069
-505,790
| -27% | -$29M |
|
|
ODP
208
DELISTED
ODP
ODP
| $76.6M | 0.09% |
851,198
+502,070
| +144% | +$44.7M |
|
209
Applied Materials
AMAT
$403B
| $76M | 0.09% |
3,452,987
-1,022,752
| -23% | -$24.5M |
|
210
CALL
Qualcomm
QCOM
$155B
| $75.3M | 0.09% |
1,091,700
-399,500
| -27% | -$28.2M |
|
|
SLXP
211
PUT
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $75.2M | 0.09% |
437,300
+336,900
| +336% | +$49.5M |
|
212
Public Storage
PSA
$60.5B
| $75.1M | 0.09% |
381,423
+62,650
| +20% | +$12.4M |
|
213
PUT
Caterpillar
CAT
$375B
| $75.1M | 0.09% |
939,000
-173,300
| -16% | -$14.4M |
|
214
CALL
Micron Technology
MU
$930B
| $75M | 0.09% |
2,777,500
-1,609,200
| -37% | -$48.1M |
|
215
Goldman Sachs
GS
$300B
| $74.9M | 0.09% |
400,699
-227,279
| -36% | -$42.3M |
|
216
Regeneron Pharmaceuticals
REGN
$78.5B
| $74.8M | 0.09% |
165,931
+60,642
| +58% | +$25.7M |
|
217
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $74.1M | 0.09% |
1,029,508
-2,807,689
| -73% | -$200M |
|
218
MetLife
MET
$61.9B
| $73.1M | 0.08% |
1,639,163
+148,353
| +10% | +$6.67M |
|
|
219
Caterpillar
CAT
$375B
| $73M | 0.08% |
912,225
+81,024
| +10% | +$6.73M |
|
220
Exelon
EXC
$47.2B
| $72.5M | 0.08% |
3,077,962
-107,002
| -3% | -$2.65M |
|
221
PUT
Home Depot
HD
$331B
| $72.4M | 0.08% |
640,800
+389,900
| +155% | +$43M |
|
222
CALL
Petrobras
PBR
$125B
| $72.2M | 0.08% |
12,035,200
+449,800
| +4% | +$2.87M |
|
|
AGN
223
PUT
DELISTED
Allergan plc
AGN
| $71.9M | 0.08% |
242,084
-1,023,459
| -81% | -$292M |
|
224
PUT
Merck
MRK
$322B
| $71.3M | 0.08% |
1,310,314
-293,860
| -18% | -$16.6M |
|
225
CALL
Procter & Gamble
PG
$336B
| $70.9M | 0.08% |
875,400
-533,300
| -38% | -$45.9M |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.